These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 8623356
1. Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival. Lucien J, Marath A, Rayat G, Thliveris J, Koshal A, Yatscoff R. Transplant Proc; 1996 Apr; 28(2):704-7. PubMed ID: 8623356 [No Abstract] [Full Text] [Related]
2. Long-term xenograft survival and suppression of xenoantibody formation in the hamster-to-rat heart transplant model using a combination therapy of leflunomide and cyclosporine. Lin Y, Sobis H, Vandeputte M, Waer M. Transplant Proc; 1994 Dec; 26(6):3202. PubMed ID: 7998115 [No Abstract] [Full Text] [Related]
3. Mechanism of leflunomide-induced prevention of xenoantibody formation and xenograft rejection in the hamster to rat heart transplantation model. Lin Y, Sobis H, Vandeputte M, Waer M. Transplant Proc; 1995 Feb; 27(1):305-6. PubMed ID: 7879012 [No Abstract] [Full Text] [Related]
4. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone. Lin Y, Sobis H, Vandeputte M, Waer M. Transplant Proc; 1994 Oct; 26(5):3052. PubMed ID: 7940959 [No Abstract] [Full Text] [Related]
6. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts. Xiao F, Chong A, Foster P, Sankary H, McChesney L, Williams JM, Frieders D, Williams JW. Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902 [No Abstract] [Full Text] [Related]
7. Newborn discordant cardiac xenotransplantation in primates: a model of natural antibody depletion. Michler RE, Xu H, O'Hair DP, Shah A, Kwiatkowski PA, Minanov O, Itescu S. Transplant Proc; 1996 Apr; 28(2):651-2. PubMed ID: 8623325 [No Abstract] [Full Text] [Related]
8. Prolongation of cardiac xenograft survival by double filtration plasmapheresis and ex vivo xenoantibody adsorption. Kimikawa M, Agishi T, Teraoka S, Suga H, Hayasaka Y, Ota K. Transplant Proc; 1992 Apr; 24(2):447. PubMed ID: 1566383 [No Abstract] [Full Text] [Related]
9. Mechanisms involved in long-term hamster-to-rat cardiac xenograft survival. Lin Y, Vandeputte M, Waer M. Transplant Proc; 1996 Apr; 28(2):683. PubMed ID: 8623343 [No Abstract] [Full Text] [Related]
10. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats. Lin Y, Vandeputte M, Waer M. Transplant Proc; 1996 Apr; 28(2):741. PubMed ID: 8623376 [No Abstract] [Full Text] [Related]
11. IgG is a prominent component of cynomolgus antiporcine natural xenoantibody. Bollinger RR, Fabian MA, Abernethy KA, Harland RC, DeBuysscher EV, Baldwin WM. Transplant Proc; 1992 Apr; 24(2):435. PubMed ID: 1566376 [No Abstract] [Full Text] [Related]
12. Prevention of induced antibody response in discordant cardiac xenotransplantation: role of the graft in total lymphoid irradiation treated recipients. Brewer RJ, Roslin MS, Del Rio MJ, Alexandropoulos I, Sadeghian M, Zisbrod Z, Burack JH, Cunningham JN, Norin AJ. Transplant Proc; 1994 Jun; 26(3):1351-2. PubMed ID: 8029936 [No Abstract] [Full Text] [Related]
17. Prolongation of survival of rat heart xenografts in C3-deficient guinea pigs. Braidley PC, Dunning JJ, Wallwork J, White DJ. Transplant Proc; 1994 Jun; 26(3):1259-60. PubMed ID: 8029901 [No Abstract] [Full Text] [Related]
18. Tetrahydropyranyladriamycin with FK 506 combination therapy for hamster-to-rat-concordant xenotransplantation. Namii Y, Yasutomi M, Hayashi S, Ito M, Ohtsuka S, Uchida K, Yokoyama I, Takagi H. Transplant Proc; 1996 Apr; 28(2):709-10. PubMed ID: 8623358 [No Abstract] [Full Text] [Related]